Overview
Matthias Fischer practices in Koeln, Germany. Mr. Fischer is highly rated in 6 conditions, according to our data. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Coffin-Lowry Syndrome, and Gliomatosis Cerebri.
His clinical research consists of co-authoring 262 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Embryonal Tumor with Multilayered Rosettes
- NeuroblastomaMr. Fischer isElite. Learn about Neuroblastoma.
- Distinguished
- Coffin-Lowry SyndromeMr. Fischer isDistinguished. Learn about Coffin-Lowry Syndrome.
- Gliomatosis CerebriMr. Fischer isDistinguished. Learn about Gliomatosis Cerebri.
- Advanced
- Cardiac ArrestMr. Fischer isAdvanced. Learn about Cardiac Arrest.
- GanglioneuromaMr. Fischer isAdvanced. Learn about Ganglioneuroma.
- Experienced
- AnaphylaxisMr. Fischer isExperienced. Learn about Anaphylaxis.
- Anaplastic Large Cell LymphomaMr. Fischer isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Bone TumorMr. Fischer isExperienced. Learn about Bone Tumor.
- Brain Stem CancerMr. Fischer isExperienced. Learn about Brain Stem Cancer.
- Brain TumorMr. Fischer isExperienced. Learn about Brain Tumor.
- COVID-19Mr. Fischer isExperienced. Learn about COVID-19.